The Europe antihypertensive drugs market is estimated to grow at a CAGR of 2.70% during the forecast period of 2019-2028. Europe accounted for the second-largest revenue share across the antihypertensive drugs market, due to key drivers like solid traction of significant players in the region and awareness regarding antihypertensive drugs to treat hypertension.
EUROPE ANTIHYPERTENSIVE DRUGS MARKET FORECAST 2019-2028
Europe Antihypertensive Drugs Market by Drug Class (Calcium Channel Blockers, Ace Inhibitors, Beta-adrenergic Blockers, Diuretics, Vasodilators, Other Drug Class) by End-user (Hospital Pharmacy, Retail Pharmacy, E-commerce Websites & Online Drug Stores) and by Geography.
The Europe antihypertensive drugs market is estimated to grow at a CAGR of 2.70% during the forecast period of 2019-2028. Europe accounted for the second-largest revenue share across the antihypertensive drugs market, due to key drivers like solid traction of significant players in the region and awareness regarding antihypertensive drugs to treat hypertension.
To know more about this report, request a free sample copy.
France, Italy, Belgium, Poland, the United Kingdom, Germany, Russia, and the rest of Europe are the countries included in evaluating the Europe antihypertensive drugs market growth. A surge in the prevalence of hypertension in Europe has led to a rise in demand for antihypertensive drugs. In the United Kingdom, over 15 million people suffer from chronic diseases, such as diabetes and Parkinson’s disease, among numerous others. According to WHO, over 85% of the total deaths in the United Kingdom are caused due to chronic diseases. Moreover, a rise in awareness regarding early hypertension diagnosis for better treatment options and management has propelled the market growth in the country. The government of France has introduced several initiatives, especially in the healthcare sector. Besides, the rising aging population is also fuelling market growth. According to statistics, the number of people above the age of 65 has increased significantly, accounting for over 5% in 2017. Furthermore, France is among the prime research and development investment destinations in Europe. These factors are responsible for driving the antihypertensive market growth in the country.
Being one of the leading pharmaceutical companies worldwide, AstraZeneca Plc (AstraZeneca) develops prescription medications in therapeutic areas like cardiovascular, oncology, respiratory, and infectious diseases. The company collaborated with ArcherDX in May 2020, to use personalized cancer assays to identify minimal residual disease in lung trials. With 31 operation locations in 18 nations, AstraZeneca’s headquarters are located in Cambridge, United Kingdom.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- MARKET DEFINITION
- KEY DRIVERS
- GROWING PREVALENCE OF HYPERTENSION ACROSS THE GLOBE
- SURGE IN DISPOSABLE INCOME AND HEALTHCARE SPENDING
- RISING AGING POPULATION
- KEY RESTRAINTS
- PATENT EXPIRATIONS
- DELAY IN PRODUCT LAUNCHES
- KEY ANALYTICS
- PORTER’S FIVE FORCE ANALYSIS
- THREAT OF NEW ENTRY
- THREAT OF SUBSTITUTION
- BUYER’S POWER
- SUPPLIER’S POWER
- COMPETITIVE RIVALRY
- REGULATORY FRAMEWORK
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY INVESTMENT INSIGHTS
- PORTER’S FIVE FORCE ANALYSIS
- MARKET BY DRUG CLASS
- CALCIUM CHANNEL BLOCKERS
- ACE INHIBITORS
- BETA-ADRENERGIC BLOCKERS
- DIURETICS
- VASODILATORS
- OTHER DRUG CLASS
- MARKET BY END-USER
- HOSPITAL PHARMACY
- RETAIL PHARMACY
- E-COMMERCE WEBSITES & ONLINE DRUG STORES
- GEOGRAPHICAL ANALYSIS
- EUROPE
- THE UNITED KINGDOM
- FRANCE
- GERMANY
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- EUROPE
- COMPANY PROFILES
- ALLERGAN PLC
- ASPIRE BARIATRICS INC
- ASTRAZENECA PLC
- BIO-RAD LABORATORIES INC
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- DAIICHI SANKYO COMPANY LIMITED
- HILL-ROM HOLDINGS INC
- JOHNSON & JOHNSON
- LUPIN LIMITED
- MEDTRONIC PLC
- MERCK & CO INC
- NOVARTIS AG
- PFIZER INC
- SANOFI
- SUN PHARMACEUTICAL INDUSTRIES LTD (RANBAXY LABORATORIES)
TABLE LIST
TABLE 1: MARKET SNAPSHOT – ANTIHYPERTENSIVE DRUGS
TABLE 2: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019, (IN $ MILLION)
TABLE 3: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028, (IN $ MILLION)
TABLE 4: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019, (IN $ MILLION)
TABLE 5: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, FORECAST YEARS, 2019-2028, (IN $ MILLION)
TABLE 6: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, HISTORIC YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
FIGURES LIST
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: OPPORTUNITY MATRIX
FIGURE 3: VENDOR LANDSCAPE
FIGURE 4: KEY INVESTMENT INSIGHTS
FIGURE 5: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, IN 2019
FIGURE 6: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY CALCIUM CHANNEL BLOCKERS, 2019-2028 (IN $ MILLION)
FIGURE 7: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY ACE INHIBITORS, 2019-2028 (IN $ MILLION)
FIGURE 8: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY BETA-ADRENERGIC BLOCKERS, 2019-2028 (IN $ MILLION)
FIGURE 9: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY DIURETICS, 2019-2028 (IN $ MILLION)
FIGURE 10: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY VASODILATORS, 2019-2028 (IN $ MILLION)
FIGURE 11: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY OTHER DRUG CLASS, 2019-2028 (IN $ MILLION)
FIGURE 12: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, IN 2019
FIGURE 13: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY HOSPITAL PHARMACY, 2019-2028 (IN $ MILLION)
FIGURE 14: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY RETAIL PHARMACY, 2019-2028 (IN $ MILLION)
FIGURE 15: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, BY E-COMMERCE WEBSITES & ONLINE DRUG STORES, 2019-2028 (IN $ MILLION)
FIGURE 16: EUROPE ANTIHYPERTENSIVE DRUGS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE 17: THE UNITED KINGDOM ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 18: FRANCE ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 19: GERMANY ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 20: ITALY ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 21: RUSSIA ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 22: BELGIUM ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 23: POLAND ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 24: REST OF EUROPE ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- THE UNITED KINGDOM
- FRANCE
- GERMANY
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- EUROPE
- MARKET BY DRUG CLASS
- CALCIUM CHANNEL BLOCKERS
- ACE INHIBITORS
- BETA-ADRENERGIC BLOCKERS
- DIURETICS
- VASODILATORS
- OTHER DRUG CLASS
- MARKET BY END-USER
- HOSPITAL PHARMACY
- RETAIL PHARMACY
- E-COMMERCE WEBSITES & ONLINE DRUG STORES
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.